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Summary 
Protein tyroslne dephosphorylation after Fas cross- 
linking occurred in Fas apoptosis-sensitive CEM-6 
cells but not in Fas apoptosls-resistant MOLT-4 cells, 
and apoptosis in the CEM-6 cells could be inhibited by 
the protein tyroslne phosphatase inhibitor, psrvana- 
date. The time course and level of dephosphorylatlon 
were correlated with Increased hematopoietlc cell pro- 
tein tyrosine phosphatase (HCP) activlty, but not with 
the activity of two other tyrosine phosphatases. The 
level of expression of HCP was correlated with Fas 
apoptosis function in eleven human and murine Fas- 
positive lymphoid cell lines. Expression of recombi- 
nant HCP In the MOLT-4 cell line converted this Fas 
apoptosis-resistant cell line to Fas apoptosis sensi- 
tive. HCP-mutant meVmeV mice exhibited Increased 
expresslon of Fas but decreased Fas-mediated apop 
tosis function in lymphold organs after anti-mouse Fas 
antibody treatment In vivo. Thus, HCP-mediated pro- 
tein dephosphorylatlon Is Involved In the delivery of 
the Fas apoptosls signal in lymphold cells. 
Introduction 
Apoptosis is a physiological process of selective cell dele- 
tion that occurs during embryogenesis, metamorphosis, 
tissue atrophy, and tumor regression (Wyllie et al., 1980; 
Walkeret al., 1988; Dukeet al., 1983; Schmid etal., 1988). 
It is a critical mechanism by which the immune system 
maintains tolerance to self-antigens, such as clonal dele- 
tion of autoreactive T and B cells (Golstein et al., 1991; 
Cohen et al., 1992). It is also a mechanism for cytotoxic T 
cell-mediated target cell lysis, and corticosteroid-induced 
death of immature lymphocytes (Ucker, 1987; Wyllie, 
1980; Kagi et al., 1994). One of the most distinctive fea- 
tures of apoptotic cell death is the extensive endonuclease 
degradation of chromosomal DNA into oligomers of about 
180 bp (Wyllie et al., 1980). Apoptosis can be provoked 
by various stimuli that result in a sequence of metabolic 
events. These events include a sustained rise in cytosolic 
ionized calcium, which, in turn, activates latent enzymes 
that contribute to the structural changes associated with 
apoptosis in many cell types (Orrenius et al., 1989; Arends 
et al., 1990; Knight et al., 1991). Apoptosis usually requires 
energy in the form of ATP and new gene expression and 
protein synthesis. This indicates that apoptosis, as op 
posed to necrosis, is an energydependent active process, 
which requires a cascade of signal-transducing events. 
It has long been appreciated that the growth and many 
functional responses of mammalian cells are regulated by 
kinase-mediated protein phosphoryiation, or phospha- 
tase-mediated protein dephosphorylation signaling path- 
ways, or both. The role of protein phosphorylation in apop 
tosis has been extensively studied. Activation of protein 
kinase C (PKC) by phorbol esters maintains cell viability 
in the absence of interleukin-2 (IL-2) in cytokinedependent 
CTLL cells, and the resistance to glucocorticoid-induced 
apoptosis in these cells requires a tyrosine kinase-depen- 
dent signal (Walker et al., 1993). Apoptosis induced by 
microtubuledisrupting drugs in the cultured human lym- 
phoma cell line, BM13874, is inhibited by a phorbol ester, 
PDBu (Takano et al., 1993). PKC activation also appears 
to suppress spontaneous apoptosis in mouse splenic B 
lymphocytes (Illera et al., 1993) and chronic lymphocytic 
leukemia lymphocytes (Forbes et al., 1992). 
In contrast, protein phosphatases, which counteract the 
action of protein kinases, have been shown to enhance 
apoptosis in many systems. Recently, specific protein de- 
phosphorylation has been observed to occur in apoptosis 
induced by ionizing radiation and heat shock in human 
lymphoid lines. Okadaic acid prevents this apoptosis by 
inhibiting protein dephosphorylation (Baxter and Lavin, 
1992). Calyculin A, another potent inhibitor of phospha- 
tase PPl and PP2A, also prevents apoptosis in Burkitt’s 
lymphoma cells exposed to y radiation or heat (Song and 
Lavin, 1993). It has been shown previously that T cell re- 
ceptor (TCR)-CDSmediated induction of apoptosis in a 
murine T cell hybridoma is inhibited by the immunosup 
pressive drugs cyclosporin A (CsA) and FK508, owing to 
their inhibitory effect on the activity of calcineurin, a cal- 
cium- and calmodulindependent serinelthreonine phos- 
phatase (Fruman el al., 1992). Taken together, these data 
suggest that protein phosphorylation and dephosphoryla- 
tion regulate apoptosis in various systems. 
The Fas antigen (CD95) is a cell surface protein ex- 
pressed on a variety of cells and tissues and belongs to 
the tumor necrosis factor/nenre growth factor (TNFINGF) 
receptor family (Itoh et al., 1991; Yonehara et al., 1989). 
Molecular cloning of the APO-l antigen showed that it 
is identical to the Fas antigen (Oehm et al., 1989). An 
anti-APO-l monoclonal antibody (MAb) induced apoptotic 
cell death in some sensitive human cell lines in vitro 
(Trauth et al., 1989). Recently, the ligand for Fas antigen 
has also been identified and characterized (Suda et al., 
1993; Takahashi et al., 1994). Mutation of the fas and fes 
ligand gene in Ipr and g/d mice, respectively, causes 
lymphoproliferation and a generalized autoimmune dis- 
ease resembling systemic lupus erythematosus (Wats- 
nabe-Fukunagaet al., 1992; Lynchet al., 1994; Takahashi 
et al., 1994). Thus, Fas is an important apoptosis molecule 
that may be involved in the pathogenesis of autoimmune 
diseases. 
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An anti-human Fas MAb induces apoptosis in some, but 
not all, cells that express the Fas antigen (Trauth et al., 
1989; Yonehara et al., 1989). This suggests that Fas- 
mediated apoptosis is not only regulated by interaction of 
Fas ligand with Fas, but also by a permissive Fas signaling 
pathway. Deletion analysis of the human Fas antigen from 
the C terminus indicated that the region homologous to 
TNF type I receptor is essential for the Fas antigen to 
transduce the signal for apoptosis into cells (Itoh and Na- 
gata, 1993). This C terminus region of the Fas antigen does 
not contain domains for kinase or phosphatase activity, 
suggesting that this region might interact with cytoplasmic 
enzymes involved in the signal transduction. However, the 
mechanisms by which the intracellular death signal is 
transduced by Fas antigen remain unclear. 
Hematopoietic cell phosphatase (HCP), primarily ex- 
pressed by hematopoieticderived cells, is a protein tyro- 
sine phosphatase (PTP) belonging to a subfamily of intra- 
cellular PTPs that consists of a structure encompassing 
two N-terminal SH2 domains, a phosphatase domain, and 
a short basic amino acid-rich tail (vi et al., 1992). It has 
also been given several other names, including PTP-1C 
(Shen et al., 1991; Zhaoet al., 1993) Src homology region 
2 (SH2) domain phosphatase (Matthews et al., 1992) Src 
homology PTP-1 (SHPTPl) (Plutzky et al., 1992a), and 
PTP nonreceptortype 8(Plutzkyet al., 1992b). Point muta- 
tions of the Hcph gene result in aberrant splicing of the 
Hcph transcript and cause severe immunodeficiency ac- 
companied by systemic autoimmune disease in mice ho- 
mozygous for the recessive allelic mutation motheaten 
(me) or viable motheaten (me? on chromosome 8 (Shultz 
et al., 1993; Tsui et al., 1993) but the role of HCP in the 
development of autoimmune phenotypes in me and me” 
mice is still unknown. In this study, Fas-mediated apop 
Figure 1. Fas Expression and Apoptosis 
Function in CEM-5 and MOLT-4 Cell Lines 
(A) Cells (109 were stained with mouse anti- 
human Fas MAb followed by anti-mouse IgM 
fluorescein isothiocyanate-conjugatsd second 
antibody. Cells (10,ooO) were then analyzed by 
FACScan. The histograms of fluorescein iso- 
thiocyanate fluorescence density are pre- 
sented. Dotted lines represent the second anti- 
body control showing no nonspecific binding 
by the second antibody as compared wlth the 
unstained cells (solii line). The densely dotted 
line represents staining with the Fas MAb with 
a separated positive peak. 
(6) CEM-5 and MOLT-4 cells (5 x 1CP) were 
incubated in 1 ml of 10% FCS in RPM1 1840 
medium and 1 us/ml of either control antibody 
or mouse anti-human Fas MAb. DNA was ex- 
tracted from the cells 4 hr later and analyzed 
in a 1% agarose gel. 
tosis signaling pathway was investigated. Our results indi- 
cated that the expression of HCP is necessary for deliv- 
ering Fas apoptosis signal in lymphoid cells. 
ReStlIt 
Disassociation of Far Exprassion from Its Function 
We screened six human and five murine lymphoid cell 
lines for expression of Fas antigen. Of the eleven cell lines, 
two, CEM-8 and MOLT-4, expressed equivalent levels of 
cell surface Fas antigen (Figure 1A). The capability of the 
Fas molecule to transduce the apoptotic signal in these 
two cell lines was investigated by analysis of anti-fas- 
induced internucleosomal DNA cleavage (Figure 1B). A 
DNA ladder indicating extensive internucleosomal DNA 
cleavage was obsenred 4 hr after incubation with anti-Fas 
antibody in CEM-8 cell line, but not in MOLT-4 cell line. 
These data indicated that Fas expressed on MOLT-4 cells 
was not functional and there might be a defect in the Fas 
signaling pathway in the MOLT-4 cell line. The apoptosis 
defect in MOLT-4 cells was Fas specific, as both CEMB 
and MOLT-4 cells have the same sensitivity to corticoste- 
roid-induced apoptosis (data not shown). 
Role of Protein Phosphorylation 
and bphosphotylatlon 
Protein phosphorylation and dephosphorylation have 
been demonstrated previously to regulate apoptosis sig- 
naling (Walker et al., 1993; lllera et al., 1993; Baxter and 
Lavin, 1992). To investigate their role in Fas-mediated 
apoptosis, CEM-8 cells were incubated with anti-Fas anti- 
body in the presence of different protein phosphorylation 
and dephosphorylation modulators. Pervanadate, a pro- 
tein tyrosine phosphatase inhibitor, dramatically inhibited 
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Figure 2. Effects of Inhibitors and Stimulators of Protein Kinase and 
Phosphataee on Fas-Mediated Apoptosis in CEM-6 Cell Line 
CEM6 cells (IV) were incubated with 1 pg/ml of anti-human Fas anti- 
body in the presence of different concentrations of pervanadate, gen- 
istein. or PMA. The cells were analyzed for apoptosis 4 hr later by the 
in situ nick translation technique. Cells undergoing apoptosis were 
quantitated using a standardized eyepiece grid at a magnification of 
25.8 x . The results represent the mean f SEM of apoptotic cells in 
25 randomly selected fields of view. 
(A) Fas-mediated apoptosis in CEM6 cells incubated with pervan- 
adate. 
(6) Fas-mediated apoptosis in CEM-5 cells incubated with genistein. 
(C) Fas-mediated apoptosis in CEM-5 cells incubated with PMA. 
(D) Inhibition of Fas-mediated apoptosis in CEM-6 cells by pervana- 
date (1 mM). 
anti-Fas-induced apoptosis in dose-dependent manner 
(10-‘-lW3 M), and 50% inhibition occurred at 0.01 mM 
(Figures 2A and 2D). Preincubation of CEM-6 cells with 
pervanadate for 10 min to 2 hr prior to Fas stimulation was 
required for maximal inhibitory effect, whereas incubation 
with pervanadate after Fas cross-linking or washing of 
cells after pervanadate treatment did not inhibit apoptosis 
(data not shown). This indicated that pervanadate blocks 
Fas apoptosis signaling at an early stage. In contrast, the 
protein kinase inhibitors, genistein (Figure2B), herbimycin 
A (1 @ml), and staurosporine (20 nfvl) (data not shown) 
had little effect on Fas-mediated apoptosis. Identical con- 
centrations of these protein kinase inhibitors were capa- 
ble of inhibiting antiCD3induced proliferation (data not 
shown). Stimulation of PKC by phorbol myristic acetate 
(PMA) inhibited apoptosis by approximately 40% at 0.2 
uM (Figure 2C). Fas expression was increased in pervana- 
dateor PMA-treated CEM-6 cells and, therefore, the inhibi- 
tion of Fas-mediated apoptosis could not be attributed to 
a decrease in Fas expression (data not shown). These 
results suggest that protein tyrosine dephosphorylation 
might be a critical biochemical event during Fas-mediated 
apoptosis. 
HCP-Msdlatsd Protein Tyroslne Dephosphorylatlon 
In Fas-Msdlated Apoptosls 
Todetermine whether protein tyrosine dephosphorylation 
occurs in Fas-mediated apoptosis, CEM6 and MOLT4 
cells were prelabeled with “PI, incubated with anti-human 
Fas or control MAb, followed by anti-mouse immunoglobu- 
lin M (IgM) treatment to enhance the cross-linking for vari- 
ous periods of time. The tyrosine-phosphorylated proteins 
were immunoprecipitated by an anti-phosphotyrosine aga- 
rose and then analyzed in SDS-PAGE gels. A rapid increase 
in protein tyrosine dephosphorylation occurred in lysates 
of CEM-6 cells after Fas cross-linking, but not in lysates 
of MOLT4cells(Figure3A). Spontaneousdephosphoryla- 
tion did not occur in either CEM6 or MOLT4 cells treated 
with the control antibody (Figure 3A). In CEM-6 cells, anti- 
Fascross-linking signaling led to dephosphorylation of two 
proteins with molecular masses of approximately 100 kDa 
and 90 kDa in 5 min. Two other proteins with molecular 
masses of approximately 60 kDa and 58 kDa were also 
tyrosine dephosphorylated in 15 min after anti-Fas anti- 
body treatment. These results suggest that protein tyro- 
sine phosphatase(s) activation was induced by apoptosis 
signaling through Fas. 
To determine which tyrosine phosphatase was activated 
by Fas signaling and was responsible for protein tyrosine 
dephosphorylation, phosphatase activity for HCP, protein 
tyrosine phosphatase-I B (PTP-1 B), and SH-protein tyro- 
sine phosphataseZ/Syp (SHPTP2/Syp) was assayed after 
immunoprecipitation with specific antibodies. HCP activity 
was rapidly induced 1 min after anti-Fas stimulation and 
reached its maximal activity in 15 min in the CEM-6 cells, 
but not in the MOLT4 cells (Figure 38). In contrast, there 
was neither early induction of the PTP-1 B activity (Figure 
38) nor detectable SHPTP2/Syp activity (data not shown) 
in both cell lines, indicating that the initial increase in tyro- 
sine phosphatase activity in CEM-6 cells was attributable 
to an increased activity of HCP. These results indicate 
that the Fas apoptosis signal induces increased HCP activ- 
ity and that HCP-mediated protein tyrosine dephosphory- 
lation may play a critical role in the Fas signaling pathway. 
As HCP activity was induced during Fas-mediated 
apoptosis, we questioned whether the cells that are resis- 
tant to Fas-mediated apoptosis have defective expression 
of HCP. Therefore, Fas-mediated apoptosis function and 
HCP expression were examined in eleven human and mu- 
rine Fas-positive lymphoid cell lines. Fas apoptosis corre- 
lated with Hcph gene expression, but not with expression 
of Fas on the cell surface (Table 1). There was abundant 
Hcph mRNA in the CEM-6 cell line, whereas no Hcph 
mRNA was detected in the MOLT4 cell line (Figure 4A), 
and both CEM6 and MOLT4 cell lines expressed equiva- 
lent levels of PTP-1 B, and both lacked detectable levels 
of SHPTP2/Syp (Figure 4B). These results suggest that 
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defective HCP expression in MOLT4 cells might result in 
resistance to Fas-mediated apoptosis. 
Fas Apoptosis Function in the MOLT-4 Cell Llne 
after Trsnsfectlon with a Hcph 
Expression Vector 
To determine further whether HCP is required for trans- 
ducing the Fas-mediated apoptosis signal, HCPdeficient 
MOLT4 cells were transfected with an expression vector 
that contains full-length Hcp/r cDNA (Capone et al., 1993) 
or with an empty vector as control. After 48 hr, Hcph was 
expressed in MOLT4 cells transfected with Hcph expres- 
sion vector as demonstrated by immunoblot analysis (Fig- 
ure 5A). The transfected MOLT4 cells were incubated with 
several concentrations of mouse anti-human Fas (0.05-l 
ug/ml) for different time periods (2-l 2 hr) and apoptosis 
was assessed by the internucleosomal DNA fragmenta- 
tion assay and in situ staining. Anti-Fas antibody induced 
apoptosis in MOLT4 cells transfected with the Hcph ex- 
pression vector, but ‘not the control vector (Figure 58). 
Increased sensitivity to Fas-mediated apoptosis in Hcph- 
transfected MOLT4 cells was demonstrated by dose and 
time course response analysis. In Hcph-transfected MOLT4 
cells, there was more than a l,CKXt-fold increase in the 
dose response to anti-Fas antibody (Figure 5C), and a 
5-fold decrease in the time required for the induction of 
apoptosis(Figure5D). These results indicate that recombi- 
nant expression of HCP restored Fas apoptosis function 
in MOLT4 cells. 
Abnormelitles of Fas Apoptosls Function In HCP 
Mutant Motheaten Mice 
Mice homozygous for the autosomal recessive motheaten 
(me), or the less severe allelic viable motheaten (me”) mu- 
tations develop severe combined immunodeficiency and 
Figure 3. Protein Tyrosine Dephosphorylation 
and Tyrosine Phosphatase Activities in Fas- 
Mediated Apoptosis 
(A) Tyrosinaphosphorylated proteins were an- 
alyzed on SDB-polyacrylamide gels after be- 
ing immunoprecipitated by anti-phosphotyro- 
sine agarose from CEM-6 and MOLT-4 cells, 
which were prelabled with =P, and then cross- 
linked with anti-Fas or control antibody for 0,5, 
and ibmin. Thesizesandpositionsofstandard 
markers are indicated. 
(B) HCP and PTP-I B were immuncprecipitated 
from GEM-6 and MOLT-4 cells at the specified 
periods of time after anti-Fas cross-linking. 
PTP activity in the immune complexes was de 
tected by an in vitro PTP assay using tyrosine 
phosphorylated raytide as a substrate. The ac- 
tivity of HCP and PTP-1B is indicated as the 
percentage of control. 
systemic autoimmunity (Sidman et al., 1989; Green and 
Shultz, 1975; Shultz, 1988; Shultz et al., 1984). Recent 
evidence suggests that mutations in the Hcph gene are 
directly responsible for the motheaten phenotype (Shultz 
et al., 1993; Tsui et al., 1993). To determine whether there 
is a defect of Fas apoptosis function in HCPdeficient moth 
eaten mice, thymocytes and splenic lymphocytes from 
both C57BL/8J-+/+ and HCP-mutant mev/mev mice were 
first examined for their Fas expression by flow cytometry 
Table 1. Correlation of Fas Expression, Apoptosis Function, and 
HCP Expression in Human and Murine Lymphoid Cell Lines 
Cell Line 
Name 
FeS 
Expres- Fas HCP&actin 
Cell Type sion Apoptosis Ratio 
Human Cell Lines 
CEM-6 T 55 >95% 1.0 
MOLT-4 T 57 <5% 0 
MOLT-3 T 55 <5% 0.05 
H9 T 120 X5% 0.8 
LBW-2 B 72 22% 0.4 
u937 Monocyte 36 10% 0.1 
Murine Cell Lines 
EL-4 T 67 12% 0.4 
YAC-1 T 34 <5% 0 
WEHI 231 B 55 44% 0.7 
WEHI 279 0 60 92% 0.9 
A20 B 72 X5% 1.2 
Fas expression was determined by flow cytometry analysis and is 
expressed as the mean fluorescence intensity. Fas apoptosis was 
determined by the in situ apoptosis staining method and is expressed 
as the percent of cells undergoing apoptosis as described in Figure 
2. HCP expression was determined by Northern blot analysis using 
the human or murine HcpIr cDNA fragment as probe, and is expressed 
as the ratio ( x 102) of HCP expression relative to 6-actin expression 
quantitated with a Phosphorlmager. 
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Fiiure4. Expression of Protein Tymaine 
Phoaphatases in CEM-6 and MOLT4 Cells 
(A) Total RNA (5 pg) from CEM-6 and MOLT4 
cells was electrophoreeed, traneferred to a ni- 
CEY+ MOLT-4 tmcellulose membrane, and hybridized with a 
spP-labeW human !@#I probe. An kkntkal 
HCP :... 65KD Motwashybridizedwithapmbefor@actin, “II _. indicating that nearly identical amount8 of RNA 
PTP-1 B 
are preknt in eack lane. The 26S and 18s 
riboeomal bands are shown to the iefl of the 
figure. 
(B)Total cellular protein lysatea were pmpared 
from CEM-6 and MOLT-4 cells, and eeparated 
by SDS-polyacrylamide gels, blotted to the ni- 
trooellubee membranes, and deteoted byanti- 
HCP, m-1 B, and SHPTP2/Sypantlbody. The 
sizes and posltiis of the PTP protein bands 
are indicated to the right of the flgure. 
analysis. Fas was expressed at equivalent levels in thymo- control mice, apoptosis was distributed predominantly in 
cytes, but at significantly higher levels in splenic lympho- a focal pattern in the outer regions of the cortex (Figure 
cytes in me%rW mice compared with control mice (Figure 78). The number of apoptotic foci was equivalent in these 
6A). Fas-mediated apoptosis function was then deter- two strains of mice. However, the average number of apop- 
mined in vivo by injecting 100 pg of hamster anti-mouse totic cells per foci in control mice was 28 f 10 compared 
Fas antibody and control hamster antibody intraperitone- with 8 f 3 in the me%w mice. Low levels of apoptmis 
ally into C57BL&l-+/+ and meWW and control mice were observed in the thymus, spleen, and peripheral 
(Ogasawara et al., 1993). Apoptosis was assessed by in lymph node after control antibody treatment, and there 
situ apoptosis staining of frozen sections. The number of was no difference between me%Wand control mice (data 
lymphocytes that had undergone apoptosis was reduced not shown). These data indicated that there was defer- 
in the thymus, spleen, and lymph node of me%W com- tive Fas apoptosis signaling in lymphoid organs in HCP- 
pared with control mice after anti-Fas treatment (Figure deficient motheaten mice. It was also noted that although 
68; Figure 7A). In the thymus of mev/mev mice as well as anti-Fas-induced apoptosis was decreased in the lym- 
CEM-6 (Cl 
MOLT-4 Control (M,) 
MOLT-4 pHcph (M,) 
B MC M” Figure 5. Fas Apoptosis Function in MOLT-i Cells after Transfeotion with Expregdar 
MOLT-4 cells (2 x IV) were bansfected with 
either the pSlX@lE vector containing the hu- 
man Ho@ gene insert or a wntrol p913CBlE 
empty vector. Tranafeclion efficiency was de- 
termined to be 40% by immunohistoohemical 
staining using anti-HCP antibody. 
(A) CEM-6 cells (C), MOLT-4 cells transfeoted 
with a control pgl3CplE empty vector (MC), 
,001 31 .1 1 10 0 7. . 6 I 10 I* 14 
Anti-b (WJlrnl, Tima (W conhol (MC) transfected MOLT-4 cells after 4 
hr incubation with the mouse anti-human Fas 
MAb (1 @ml). 
(C) CEM-6 (C) and Hcph (M,,) or control (k&) transfected MOLT4 cells were incubated with mouse anti-human Fas MAb at different concentrations 
(0.05-I &ml) for 6 hr. Apoptosis was assessed and quantitakl by in situ apoptosis staining as detailed in Figure 2. 
(0) CEM-6 and transfected cells were incubated with mouss anti-human Fas MAb at 1 &ml for different periods of time (2-12 hr). &OPtOSiS WaS 
assessed and quantitated by in situ apoptosis staining as detailed in Figure 2. 
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Figure 6. Fas Expression and Apoptosis 
Function in Motheaten and Normal Mice 
a C57BUG+l+ (A) Single-cell suspensions (lq from thymus (Thy) and spleen (Sp) of C57BLfBJ-+/+ and 
0 mc”lme* me%n# mice were stained with phycoerythrtn- 
conjugated hamster anti-mouss Fas antibody 
or irrelevant control antibody. Viabte cell0 
(10,000) were then anatyzed by FACScan. The 
solid lines represent the staining wlth the anti- 
& mouse Fas antibody, and the dotted lines rep 
resent the control antlbody statning. 
(B) For in vtvo anafysts, C57BL/5&+/+ and 
meVme~ mice were injscted with 100 ug (lntra- 
Thymus 
perttoneally) of anti-mouse Fas antibody. Thy- 
Spleen LN mu8 (Thy), spleen (Sp), and lymph node (LN) 
secttons were prepared 2 hr after injsction of 
three 5week-old mice. The percent of apoptosis cells was determined as described in Figure 2 and quantitated by counting apoptotic and 
nonapoptotic cells in 25 randomly selected fields of view using a standardized eyepiece grid. The MEAN f SEM for three different mice are 
phoid organs from HCPdeficient rrW/rrW mice, there 
were equivalent levels of Fas-mediated apoptosis in the 
hepatocytes (approximately 75%), which caused equiva- 
lent mortality in both strains of mice. These results imply 
that HCP-mediated Fas apoptosis signaling is limited in 
lymphoid cells, whereas other signaling molecules may 
be utilized in Fas-induced apoptosis pathways in the liver. 
Discussion 
Our interest in the mechanism of Fas/APO-1 apoptosis 
signaling arose from the observation that anti-Fas/APO-1 
antibody could mediate apoptosis in some, but not all, cell 
lines that express the Fas molecule. After analyzing Fas 
expression and function in several cell lines, we found that 
the MOLT-4 cell line expressed equivalent levels of the 
Fas antigen as the CEM-9 cell line, but was resistant to 
anti-Fas-induced apoptosis. Therefore, the presence of 
Fas/APO-1 antigen on the cell surface was not sufficient 
to execute the anti-Fas-induced signal for cell death. 
Several signal transduction modulators were assessed 
for their effects on Fas-mediated apoptosis in CEM-9 cell 
line. Pervanadate, a protein tyrosine phosphatase inhibi- 
A 
meVme” 
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tor, dramatically reduced Fas-mediated apoptosis in 
CEM-6 cells, suggesting that Fas-mediated apoptosis in 
this cell line is dependent on protein tyrosine phosphatase 
activity. Analysis of tyrosine-phosphotylated proteins by 
immunoprecipitation using anti-phosphotyrosine agarose 
indicated that several proteins in cytosolic extracts of 
CEM-9 cells were rapidly dephosphorytated after incuba- 
tion with anti-Fas antibody, whereas no protein dephos- 
phorylation was observed in cytosolic extracts from the 
Fas apoptosis-resistant MOLT-4 cells. This protein tyro- 
sine dephosphorylation correlated with rapid induction of 
HCP activity in CEM-9 cells. Expression of Hcph in CEM-9 
as well as other Fas-positive lymphoid cell lines correlated 
with their Fas-mediated apoptosis function. Transfectfon 
of a Hcph expression vector into Hcph negative MOLT4 
cells partially restored the Fas-mediated apoptosis func- 
tion. Based on these observations, we proposed that HCP 
might be responsible for Fas-mediated apoptosis signal- 
ing transduction in certain cell lines. This is consistent with 
previous observations that HCP negatively regulates cell 
growth through association of its SH2 domains with tyro- 
sine phosphorylated c-Kit as well as the IL-3 receptor (vi 
and Ihle, 1993; Yi et al., 1993). 
The extracellular and intracellular signaling domains of 
Figure 7. Decreased Fas Apoptosis Function 
in me%ne” Mice 
(A) Apoptosis in the thymus, spteen, and lymph 
node of C57BLBJ-+/+ and rrW/rrW mice was 
determined by the in situ apoptceis statning 
method as detailed in Figure 2 and Ftgure 68 
(magnification, 6x). 
(B) Cells undergoing apoptosts in the outer cor- 
tex of the thymus of C57BUBJ-+/+ and me”/ 
rnw mice were anafvzed as described in Future 
2 and Figure 6B (magnification, 24x). - 
LN 
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Fas antigen are similar to those of TNF/NGF receptor fam- 
ily, which includes the low affinity NGF receptor, TNF re- 
ceptors, CD27, CD39 CD49, and OX40 (Itoh et al., 1991). 
No intrinsic kinaseor phosphataseactivity has been identi- 
fied in the cytoplasmic region of Fas. However, a domain 
has been identified in the cytoplasmic region that is re 
quired for transduction of the signal for cell death (Itoh and 
Nagata, 1993). Whether this apoptotic signal-transducing 
domain exerts its function through the interaction with 
HCP remains to be clarified. Based on the recent descrip- 
tlon of TNF receptor-associated factors (TRAFl and TRAF2) 
(Rothe et al., 1994), it is possible that HCP is indirectly acti- 
vated through other proteins that coupled to the Fas intra- 
cellular domain. In addition, a sphingomyelinase-cera- 
mide signaling mechanism for phosphatase activation by 
the TNF-R has been described (Kolesnick and Golde, 
1994; Kim et al., 1991; Mathiaset al., 1991; Ballou, 1992) 
and this pathway has been demonstrated to be important 
in ceramide-induced apoptosis (Jarvis et al., 1994; Obeid 
et al., 1993). Whether HCP is activated through sphingo- 
myelinase-ceramide pathway is under investigation. 
The Hcph gene has been defined as the homozygous 
recessive atlelic mutation in the motheaten (me) mice on 
chromosome 6 (Shultzet al., 1993; Tsui et at., 1993). These 
mice develop abnormalities in T cells, B ceils, and macro- 
phages, increased autoantibody production, and immune 
deficiency (Sidman et at., 1989; Green and Shultz, 1975; 
Shultz, 1988; Shultz et al., 1964). Although HCP has been 
identified as a mutant gene in this mouse strain, the func- 
tion of HCP and the mechanism(s) by which autoimmune 
disease developed are still unknown. Our results indicated 
that despite increased Fas expression in the spleen of 
me%ney mice, there was defective Fas apoptosis function 
in thymocytes and peripheral lymphocytes. This defective 
Fas apoptosis function may be caused by defective HCP 
expression that leads to defective Fas signaling in lym- 
phoid cells of these mice. The observation that the HCP 
defect reduces lymphoid cell apoptosis but not hepatocyte 
apoptosis in meVmeY mice suggests that Fas uses different 
signaling pathways in different cell types. This regulation 
of Fas-mediated apoptosis at the signal transduction level 
may be an important mechanism to induce and regulate 
Far+mediated apoptosis selectively in the presence of 
equivalent levels of Fas and Fas ligand expression. This 
demonstrates that HCP may function as a Fas apoptosis 
signaling molecule and that this HCP deficiency is linked 
to a Fas-mediated apoptosis defect in the immune system 
in this mouse model. 
Although Fas-deficient /prnpr and HCP-deficient me/me 
mice develop different cellular phenotypes, both of them 
share some common features of autoimmunity, such as 
splenomegaly, autoantibody production, and glomerulo- 
nephritis (Cohen and Eisenberg, 1991; Samelson et al., 
1996; Budd et al., 1992). The differences between the 
autoimmune disease of Ipr mice and me mice indicate that 
defective expression of the Fas apoptosis molecule in Ipf 
immune features identical to those observed with low ex- 
pression of the protein tyrosine phosphatase in me mice. 
One explanation may be that Fas signaling leads to signal 
transduction through multiple pathways. Recent evidence 
that supports this hypothesis is the description of other 
potential signaling pathways that can be induced by Fas 
stimulation (D. Green, personal communications). This 
concept is also consistent with our observations that equiv- 
alent levels of Fas-mediated apoptosis occur in liver from 
normal double-positive and HCPdeficient me/me mice, 
and that okadaic acid, a serine/threonine phosphatase in- 
hibitor, can also partially inhibit Fas-mediated apoptosis 
in CEM-6 cells (data not shown). The signaling pathway 
utilizing the HCP phosphatase is important for apoptosis 
signaling, but other signaling pathways may be critical 
for other functions mediated by the Fas molecule. This 
concept is consistent with the finding that HCP is highly 
expressed in the tracheobronchial cells, lung, and kidney 
(Plutzky et al., 1992a). This multifunctional view of Fas is 
supported by the obsenration that the Fas molecule can 
transduce a costimulatory signal in developing thymo- 
cytes (Alderson et al., 1993). Also, Fas signaling might 
utilize different pathways at different stages of lymphocyte 
development. Fas signaling mediated through the HCP 
phosphatase pathway may be important at an early stage 
of hematopoietic cell development (Shultz, 1991; Hayes 
et al., 1992), whereas defective expression of the Fas mol- 
ecule in Ipr mice would prevent signaling through the Fas 
molecule at all stages of lymphocyte development (Wata- 
nabe-Fukunagaet al., 1992). Finally, HCP may be involved 
in signal transduction initiated by cell surface molecules 
in addition to the Fas molecule. Therefore, it is not surpris- 
ing that the consequence of the Hcph gene defect in me 
mice is not equivalent to the fas gene defect in Ipr mice, 
despite the utilization of HCP as a second messenger in 
Fas-mediated apoptosis by some cells. 
The present study provides promising intervention 
points for apoptosis signaling. The apoptosis defect ob- 
served in MOLT-4 cells could conceivably be overcome 
by supplying a phosphatase activity or inhibiting a phos- 
phorylation activity. Further understanding of the interplay 
between phosphorylation and dephosphorylation events 
mediated by protein tyrosine kinase and phosphatase will 
be critical to the identification of pharmacologic targets 
for modulation of apoptosis. 
Experimental Procedure8 
Ylce 
The C57BU5J-+/+ and C57BUW viable homozygous motheaten 
(meVAne’) mice were purchased from the Jackson Laboratory (Bar Har- 
bor, Maine). Mice were used at 0 weeks of age. 
Cell and Cell Culture 
The CEM-O, MOLT-t, MOLT-3, LBW-2, U937, H9, EL-l, YAC-1, WEHI 
231, WEHI 279, and A20 cell lines were obtained from American Type 
Culture Collection (Rockvtlle, Maryland) and were cultured at 37OC 
and 5% CQ in RPM1 1840 medium supplemented with 19% heat- 
inactivated fetal calf serum (FCS), 10 mM sodium bicarbonate, 10 
mM HEPES, 100 U/ml penicillin, 199 pg/mi streptomycin, and 2 mM 
glutamine. 
Antlbodiw and Magenta 
Mouse anti-human Fas MAb. rabbit anti-human SHPTPl (HCP), PTP- 
18, and SHPTPVSyp polycionai antibody were purchased from Up 
state Biotechnology, Incorporated (Lake Placid, New York). Goat anti- 
rabbit @G-horseradish peroxidase was obtained from Boehringer 
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Mnnheim Corporation (Indiiapolia, India) and an&mouse IgM an- 
tlbodywas obtained from Phamrigen (San Dtego, California). The ham- 
ster admouse Fas antibody was generated in our laboratory (T. 2. 
et al., unpublished data). Monocbnal mouse antwne 
agarose. gentstein, PMA, and sodium om te were purchased 
from Sigma (St. Louis, Mlesourii. Pervanadate (vanadyi hydroperox- 
Me) was prepared as described (Pumtglta et al., 1992). Raytide and 
Peep- protein tyrosine kinase were purchased from Oncogene Sci- 
ence, lnaxporated (Uniondale. New York). 
DNAPlokr 
The DNA fragments of human and murine Ncp/r gene (nucleotides 
251-105Oand nucleotldes551-128O)werederivedfrom revemetran- 
scrtptbn+olymerase chain reaction (RT-PCR) ampliication of cDNA 
prepared from CEM-8 and EL4 total RNA (2-4 ug) using an RNA PCR 
kit (Perkin-Elmer Coqmmtbn, Norwalk, Connecticut) (vi et al., 1992) 
reepectfvely. Sequenceswere confirmed by DNAsequencing analysis 
using the didsoxy chain terminatlon method (vi et al., 1992). The 
pmkrbe was obtained from Oncor, Incorporated (Gaithersburg, 
For Fas expression analysis of human cell lines, cells (lg were 
stainedwithoptimal concentrationsofmoussanti-human Fasantibody 
in PBS with 5% FCS and 0.1% sodium azide (NaN,) at room tempera- 
tumfor2Omin, followedbyincubation with eitherfluorescein isothiocy- 
anate-conjugatad anti-mouse IgM or control antibody with irrelevant 
epec&ky at room temperatun for 20 min. For Fas expression analysis 
of murine lymphoid organs, single-cell suspensions (1 @were stained 
wkh phycoerymrinoonjugated hamster anti-mouse Fas antibody or 
wntrol antibody in PBS with 5% FCS and 0.1% sodium azide (NaNs) 
at mom temperature for 20 min. Viable cells (10,000) were analyzed 
by flow cytometry on a FAGS-Scan (Becton Dickinson, Mountain View, 
California) with logarithmic scales. 
Gel Ekmophoreats DNA Fragmentatlon Aesay 
CelN (5 x lorlrnl) were cultured in 8-well sterile dishes (Corning Glass 
Works, Corning, New York) with mouse anti-human Fas MAb or control 
antibody with irrelevant specificity (1 rig/ml) for 4 hr. The cells were 
then wllected and tysed with 500 ul of lysis buffer containing 50 mM 
NaCI, 10 mM Tris, 5 mM EDTA, and 0.1% SDS. Lysates were then 
subjected to proteinase K digestion (109 rig/ml) at 42*C for 1 hr. The 
DNAwas extracted with phenol(pH 7) phenol:chloroform:isoamylalco- 
hol(5Oz49:l) ethanol precipitated, and then dried in a Speedvac wn- 
centrator(Savant Instruments, Incorporated, Farmingdale, New York), 
resuspended in Tris-EDTA buffer and analyzed by electrophoresis on 
a 1% agaroee gel. 
f?egulatlon of Apoptoels by Inhlbltom and Stlmulaton of 
Proteln Klneee and Phoephateee 
CEM-8 cells (lOt cells/ml) were incubated with mouse anti-human Fas 
antibody (1 @ml final concentration) in the presence of different wn- 
centrations of pervanadate (0.0001-l .O mM), genistein (0.03-0.5 ug/ 
ml), or PMA (0.12-2.0 CM). Cell viability was analyzed by the in situ 
apoptosis staining method after 4 hr. 
In Situ Apoptoele Stalnlng 
In situ apoptosis staining was carried out as described previously, with 
modification (Gavrieli et al., 1992). Cells were harvested and cytospun 
onto poly+lysine precoated sliies and fixed in 10% formalin at room 
temperature for 1 hr. Tissue sections for slides were snap frozen, 
sectioned, and treated similarly. After rinsing with distilled water, pro- 
teins were stripped from cells by incubation with 20 fig/ml proteinase 
K at room temperature for 15 min, and the slides were then washed 
four times with distilled water for 2 min each. Slides were immersed 
inTdTbuffer(3OmMTrizrnabase(pH7.2], 14OmMsodiumcacodyiate, 
1 mM cobalt chloride). TdT (0.3 U/ml) and digitonigen-modified dUTP 
in TdT buffer were added and the slides were incubated in a humid 
atmosphere at 37OC for 1 hr. The reactbn was terminated by washing 
the slides with PBS at mom temprature. After the slides were dipped 
in 10% FCS in PBS at room temperature for 30 min and dried, they 
were covered with alkaline phosphatase-m njugated antidigitonigen 
antibody and incubated at room temperature for 80 min. The slides 
were then washed with PBS and statned with nitrobiue tetrazoliuml 
5bromo4chbroSindolyl phosphate (Sigma, St. Louis, Missouri) at 
mom temperature for approximately 30 min. 
For ‘P, labeling, CEM-8 and MOLT-4 cells (5 x l(Plml) were preincu- 
bated in phosphate-free RPM1 1840 medium supplemented with 10% 
dialyzed FCS for 90 min, followed by incubation with 0.2 mCi of =PI 
per ml for 2 hr. The cells were then washed twice with ice&d RPM1 
1840 medium and anti-human Fas MAb (1 uglml) or control antibody 
was added. After 10 min on ice, anti-mouse IgM (0.5 u@ml) was added 
to promote the cross-linking, and the cells wereincubated at 37OC for 
0, 5, and 15 min. The cells were then lysed at 2.5 x 10 per 500 ul 
of Nonidet P-40 (NP-40) buffer (150 mM NaCI, 50 mM Tris-HCI [pH 
8.0].0.5% NP4gO.5 mM ZnC12, 1 mM NasVO,, 50 mM NaF) containing 
leupeptin (1 ug/ml), sprotinin (1 nglml), pepstatin A (1 @ml), antipain 
(1 &ml), and phenyimethylaulfonyl fluoride (20 uglml). Cell lysates 
were clarified by centrifugation for 30 min at 14,008 rpm at 4OC, fol- 
lowed bytheadditionof 1OOuloffixedStaphybcoccusaureus(Pansor- 
bin; Calbiochem) for 1 hr at 4OC. The immunoprecipitations were car- 
ded out by incubating the cell lysates with anti-phosphotyrosine 
agarose at 4OC for 2 hr with gentle agitation. The immune complexes 
were then washed five timeswith cold NP-40 lysis buffer and denatured 
in SDS sample buffer. The samples were then analyzed in 10% SDS- 
PAGE gels, followed by autoradiography at -7O*C. 
Phoephateee Activity Auay 
After CEM-8 and MOLT-4 cells were treated with anti-Fas antibody for 
different periods of time, total cellular protein lysates were prepared 
by treating the cells (5 x Iv with lysis buffer (20 mM Tris-HCI [pH 
8.0],150 mM NaCI, 1 mM EDTA, 1% [v/v] Triton X-100,1 mM PMSF, 
0.04% bovineserumalbumin)at4°Cfor30min, followed bycentrifuge 
at 4OC for 20 min. Anti-HCP, anti-PTPlB, or antiSHPTP2/Syp anti- 
body (2 pg) was incubated with each cell lysate sample at 4OC for 
80 min with gentle agitation. Immune complexes were absorbed with 
anti-rabbit IgG protein A-agarose (Sigma, St. Louis, Missouri) at 4OC 
for 30 min and washed four times with cold phosphatase assay buffer 
(25 mM HEPES [pH 7.31, 5 mf.4 EDTA, 10 mM dithiothreitol). The 
synthetic peptide, raytide, was labeled at its tyrosine residue using 
[ys1P]ATP and p80- protein tyrosine kinase as described (Streuli et 
al., 1990). The labeled protein was precipitated with 20% (w/v) trichlo- 
roacetic acid in 20 mM NaHtPD,, and dissolved in 0.2 M Tris-HCI (pH 
8.0). The phosphatase activity assays were performed as previously 
described (Streuli et al., 1990). 
Northern Slot Analyels of Hcph Expmeelon 
Human or murine cells(2 x 103 were homogenized and total RNAwas 
extracted from the homogenates by the guanidinium-isothiocyanate 
method (Chirgwin et al., 1979). Equivalent amounts of total RNA (5 pg) 
from each cell line were denatured at 85OC for 5 min in electrophoresis 
buffer(0.4 M 3morpholinopropanesulfonicacid. 0.1 M sodium acetate, 
2 mM EDTA [pH 7.01) containing 8% formaldehyde and 50% for- 
mamide, and size fractionated by electrophoresis through 1% agarose 
gel containing 0.6% formaldehyde. RNA was transferred to a nitrocel- 
lulose membrane (Nitroplus 2OCQ Micron Separations, Incorporated. 
Eastboro, Massachusetts) and baked for 2 hr at 80°C in a vacuum 
oven. The membrane was prehybridized and then hybridized with a 
PP-labeled 808 bp human or 730 bp murine Hcph cDNA probe. The 
membrane was then washed with 2 x SSC plus 0.1% SDS at room 
temperature for 30 min and then with 0.1 x SSC plus 0.1% SDS at 
80°C for 30 min. and exposed to XAR-2 film (Eastman Kodak, Roches- 
ter, New York) with an intensifying screen at -7OOC. The membranes 
were then extensively washed to remove residual probe and rehybrid- 
ized with a probe for 8-actin under identical conditions. 
Expreeelon of Proteln Tyroelne Phoephataeee 
CEM-8 and MOLT-4 cells (10s) were fysed in lysis buffer (1 M Tris- 
HCI [pH 7.51, 0.5% Triton X-100, 1 mM PMSF, 1 ug/ml leupeptin, 
1 &ml aprotinin, and 1 mM sodium orthovanadate) and equivalent 
amounts of total cellular protein lysates (20 j4g) were separated on 
10% SDS-polyactylamide gels, blotted to nitrocellulose membranes 
(BieRad Laboratories, Hercules, California), and incubated with rabbit 
anti-human SHPTPl (HCP)or PTP-1 B or SHPTP2/Syp polyclonal anti- 
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body. The blots were counterstained with goat anti-rabbit IgG conju- 
gated with horseradish peroxidase, and incubated with chemilu- 
minescence detection reagents (Bcehringer Mannheim Corporation, 
Indianapolis, Indiana) including lumind, Qiodophenol, and Ha* at 
room temperature for 1 min, followed by exposure to XAR-2 film (East- 
man Kodak, Rochester, New York) with an intensifying screen at room 
temperature for 1 min. 
Construct and Expmulon of Recombinant Hcph Gene 
The full-length 1937 bp human HCP cDNA fragment corresponding 
to nucleotides 28-1984 was amplified by RT-PCR from total RNA 
isolated from CEM-8 cells as follows: 30 cycles at 94% for 1 min, at 
58% for 1.5 min, and at 72% for 2 min. The primers used for RT- 
PCR were S-AGACTAGCTGCACCTCCT-3’ (nucleotides 28-45) and 
5’~CGACATCTCCTAGGTTCA-3’ (complementary to nucleotides 
1947-1984). The amplifted HCP cDNA fragment was directly sub- 
cloned into pCR vector (Invitrogen, San Diego, Caltfomia), following 
the procedures recommended by the manufacturer, and DNA se- 
quencing analysis revealed that the insert cDNA sequence was identi- 
cal to the published sequence (Yi et al., 1992). The insert was then 
excised by EcoRl and subcloned into the BamHl site of the p913C51 E 
vector (provlded by Dr. C. Weaver at University of Alabama at Bir- 
mingham) in front of TCR Vjl gene and 8 chain enhancer, which has 
been described to allow T cell-specific expression (Capone et at., 
1993). MOLT4cells(2 x lq were transfected with 5 pg of pSlX8lE 
vector containing human Hcph gene insert or empty p913Cj3lE vector 
ascontrolbylipofectin(lOug)in 1 mlofserumfreeRPMll84tImedium 
at 37%. After 48 hr, the expression of recombinant Hcph gene in 
transfected cellswas detected by immunoblot using anti-HCP antibody 
as described above. Transfection efficiency was determined by immu- 
nohistochemical staining using the anti-HCP antibody following the 
procedures suggested by the manufacturer. 
In Vlvo Afmptosfs Auay 
Hamster anti-mouse Fas antibody and control antibody (100 pg) puri- 
fied under identical conditions were injected intraperitoneally into three 
6weekold C57BL/8J-+/+ and me%nev mice, respectively. Thymus, 
spleen, and lymph node sections were prepared 2 hr after injection. 
The apoptosis was analyzed by in situ apoptosis staining as described 
above. 
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